Skip to main content
· 4/4/2014

Linda Messick v. Novartis Pharmaceuticals Corp.

Citations

  • 747 F.3d 1193
  • 94 Fed. R. Serv. 153
  • 2014 WL 1328182
  • 2014 U.S. App. LEXIS 6257

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • holding that the district court abused its discretion when it excluded expert testimony as unreliable because the expert could not determine which of multiple risk factors caused plaintiffs disease
  • acknowledging that, even if a medical expert’s report prepared without examination or interview of the subject is in some instances admissible, the factfinder must still determine its weight
  • reversing grant of summary judgment where expert’s testimony, which would have created a genuine issue of material fact, was excluded because it was erroneously deemed unreliable and irrelevant
  • finding expert’s testimony relevant and reliable, but fact issues precluded summary 17 judgment on products liability claims
  • reversing grant of summary judgment where expert’s testimony, which would have created a genuine issue PYRAMID TECH. V. ALLIED PUBLIC ADJUSTERS 15 of material fact, was excluded because it was erroneously deemed unreliable and irrelevant
  • reversing grant of summary judgment where expert’s testimony, which would have created a genuine issue of material fact, was excluded because it was erroneously deemed unreliable and irrelevant

Source: CourtListener parenthetical corpus (CC0).

Judges: Fisher, Gould, Christen

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.